Spatial and functional targeting of intratumoral Tregs reverses CD8+ T cell exhaustion and promotes cancer immunotherapy
Journal of Clinical Investigation · 2024
DOI: 10.1172/jci180080 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2024. Verfasst von Lei Zhou und 15 weiteren Autor:innen. Beteiligte Einrichtung: Pelotonia Institute for Immuno-Oncology (PIIO), The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Ins…. Hauptthemen laut MEDLINE: T-Lymphocytes, Regulatory, CD8-Positive T-Lymphocytes, Immunotherapy, Tumor Microenvironment. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIAID NIH HHS, National Cancer Institute.
Abstract (Originalsprache)
Intratumoral Tregs are key mediators of cancer immunotherapy resistance, including anti–programmed cell death (ligand) 1 [anti–PD-(L)1] immune checkpoint blockade (ICB). The mechanisms driving Treg infiltration into the tumor microenvironment (TME) and the consequence on CD8 + T cell exhaustion remain elusive. Here, we report that heat shock protein gp96 (also known as GRP94) was indispensable for Treg tumor infiltration, primarily through the roles of gp96 in chaperoning integrins. Among various gp96-dependent integrins, we found that only LFA-1 (αL integrin), and not αV, CD103 (αE), or β7 integrin, was required for Treg tumor homing. Loss of Treg infiltration into the TME by genetic deletion of gp96/LFA-1 potently induced rejection of tumors in multiple ICB-resistant murine cancer models in a CD8 + T cell–dependent manner, without loss of self-tolerance. Moreover, gp96 deletion impeded Treg activation primarily by suppressing IL-2/STAT5 signaling, which also contributed to tumor regression. By competing for intratumoral IL-2, Tregs prevented the activation of CD8 + tumor-infiltrating lymphocytes, drove thymocyte selection-associated high mobility group box protein (TOX) induction, and induced bona fide CD8 + T cell exhaustion. By contrast, Treg ablation led to striking CD8 + T cell activation without TOX induction, demonstrating clear uncoupling of the 2 processes. Our study reveals that the gp96/LFA-1 axis plays a fundamental role in Treg biology and suggests that Treg-specific gp96/LFA-1 targeting represents a valuable strategy for cancer immunotherapy without inflicting autoinflammatory conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pelotonia Institute for Immuno-Oncology (PIIO), The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute (OSUCCC), Columbus, Ohio, USA.
- Department of Anesthesiology, The Third Xiangya Hospital, Central South University, Changsha, Hunan, China.
- Molecular, Cellular and Developmental Biology Graduate Program, Ohio State University, Columbus, Ohio, USA.
- Department of Biomedical Informatics.
- Department of Internal Medicine, Ohio State University College of Medicine, Columbus, USA.
- Division of Medical Oncology, Department of Internal Medicine, Ohio State University Comprehensive Cancer Center, Columbus, USA.
Förderung
- NCI NIH HHS
- NIAID NIH HHS
- National Cancer Institute
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Zhou, L., Velegraki, M., Wang, Y., Mandula, J. K., Chang, Y., Liu, W., Song, N. J., Kwon, H., Xiao, T., Bolyard, C., Hong, F., Xin, G., Ma, Q., Rubinstein, M. P., Wen, H., & Li, Z. (2024). Spatial and functional targeting of intratumoral Tregs reverses CD8+ T cell exhaustion and promotes cancer immunotherapy. Journal of Clinical Investigation. https://doi.org/10.1172/jci180080
Vancouver
Zhou L, Velegraki M, Wang Y, Mandula JK, Chang Y, Liu W, et al. Spatial and functional targeting of intratumoral Tregs reverses CD8+ T cell exhaustion and promotes cancer immunotherapy. Journal of Clinical Investigation. 2024. doi:10.1172/jci180080
BibTeX
@article{Zhou2024,
author = {Zhou, Lei and Velegraki, Maria and Wang, Yi and Mandula, J K and Chang, Yuzhou and Liu, Weiwei and Song, No-Joon and Kwon, Hyunwoo and Xiao, Tong and Bolyard, Chelsea and Hong, Feng and Xin, Gang and Ma, Qin and Rubinstein, Mark P and Wen, Haitao and Li, Zihai},
title = {Spatial and functional targeting of intratumoral Tregs reverses CD8+ T cell exhaustion and promotes cancer immunotherapy},
journal = {Journal of Clinical Investigation},
year = {2024},
doi = {10.1172/jci180080}
}
EUVIMED